Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

26 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Paroxysmal Hemicrania.
Osman C, Bahra A. Osman C, et al. Among authors: bahra a. Ann Indian Acad Neurol. 2018 Apr;21(Suppl 1):S16-S22. doi: 10.4103/aian.AIAN_317_17. Ann Indian Acad Neurol. 2018. PMID: 29720814 Free PMC article. Review.
Headache and migraine.
Bahra A. Bahra A. Br J Hosp Med (Lond). 2007 Apr;68(4):195-200. Br J Hosp Med (Lond). 2007. PMID: 17465093 Review.
Cluster headache: a prospective clinical study with diagnostic implications.
Bahra A, May A, Goadsby PJ. Bahra A, et al. Neurology. 2002 Feb 12;58(3):354-61. doi: 10.1212/wnl.58.3.354. Neurology. 2002. PMID: 11839832 No abstract available.
Familial hemicrania continua.
Weatherall MW, Bahra A. Weatherall MW, et al. Among authors: bahra a. Cephalalgia. 2011 Jan;31(2):245-9. doi: 10.1177/0333102410383061. Epub 2010 Oct 18. Cephalalgia. 2011. PMID: 20956404
Other primary headaches.
Bahra A. Bahra A. Ann Indian Acad Neurol. 2012 Aug;15(Suppl 1):S66-71. doi: 10.4103/0972-2327.100012. Ann Indian Acad Neurol. 2012. PMID: 23024566 Free PMC article.
PET and MRA findings in cluster headache and MRA in experimental pain.
May A, Bahra A, Büchel C, Frackowiak RS, Goadsby PJ. May A, et al. Neurology. 2000 Nov 14;55(9):1328-35. doi: 10.1212/wnl.55.9.1328. Neurology. 2000. PMID: 11087776
BACKGROUND: Cluster headache (CH), like migraine, is still regarded as a vascular headache although in both conditions a CNS cause has been suggested. ...These data confirm that CH is a CNS disorder best considered as a form of neurovascular headache.. …
BACKGROUND: Cluster headache (CH), like migraine, is still regarded as a vascular headache although in both conditions a CNS c …
Oral zolmitriptan is effective in the acute treatment of cluster headache.
Bahra A, Gawel MJ, Hardebo JE, Millson D, Breen SA, Goadsby PJ. Bahra A, et al. Neurology. 2000 May 9;54(9):1832-9. doi: 10.1212/wnl.54.9.1832. Neurology. 2000. PMID: 10802793 Clinical Trial.
Headache intensity was rated by a five-point scale: none, mild, moderate, severe, or very severe. Patients only treated moderate to very severe headaches. ...RESULTS: A total of 124 patients took at least one dose of study medication, with 73% having episodic and 27 …
Headache intensity was rated by a five-point scale: none, mild, moderate, severe, or very severe. Patients only treated moderate to v …
Functional magnetic resonance imaging in spontaneous attacks of SUNCT: short-lasting neuralgiform headache with conjunctival injection and tearing.
May A, Bahra A, Büchel C, Turner R, Goadsby PJ. May A, et al. Ann Neurol. 1999 Nov;46(5):791-4. doi: 10.1002/1531-8249(199911)46:5<791::aid-ana18>3.0.co;2-8. Ann Neurol. 1999. PMID: 10554000
A 71-year-old woman presented with a short history of episodes of severe left-sided orbital and temporal pain in paroxysms lasting 60 to 90 seconds, and accompanied by ipsilateral lacrimation of the eye, rhinorrhea, and conjunctival injection. Results of clinical ex
A 71-year-old woman presented with a short history of episodes of severe left-sided orbital and temporal pain in paroxysms las
Medication-overuse headache in patients with cluster headache.
Paemeleire K, Bahra A, Evers S, Matharu MS, Goadsby PJ. Paemeleire K, et al. Among authors: bahra a. Neurology. 2006 Jul 11;67(1):109-13. doi: 10.1212/01.wnl.0000223332.35936.6e. Neurology. 2006. PMID: 16832088 Clinical Trial.
Intranasal sumatriptan in cluster headache: randomized placebo-controlled double-blind study.
van Vliet JA, Bahra A, Martin V, Ramadan N, Aurora SK, Mathew NT, Ferrari MD, Goadsby PJ. van Vliet JA, et al. Neurology. 2003 Feb 25;60(4):630-3. doi: 10.1212/01.wnl.0000046589.45855.30. Neurology. 2003. PMID: 12601104 Clinical Trial.
They scored their headache on a five-point scale (very severe, severe, moderate, mild, or none) at 5, 10, 15, 20, and 30 minutes. The primary outcome measure was headache response (a decrease in pain from very severe, severe, or moderate to mild or none) at 30 minut …
They scored their headache on a five-point scale (very severe, severe, moderate, mild, or none) at 5, 10, 15, 20, and 30 minutes. The …
26 results
Jump to page
Feedback